Insmed Inc revenue
Insmed Inc's revenue was $606m in fiscal 2025, up 66.7% on the year before. Since fiscal 2009 ($10.4m) it has grown at a compound 31.2% a year. Over the last twelve months it was $1.52bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 10 | 7 | 4 | 0 | 12 | 0 | 0 | 0 | 10 | 136 | 164 | 188 | 245 | 305 | 364 | 606 | 1,520 |
| Growth on the year before | — | −33.3% | −36.2% | −100.0% | — | −100.0% | — | — | — | +>999% | +20.5% | +14.6% | +30.2% | +24.4% | +19.2% | +66.7% | — |
| Gross profit | — | — | — | — | — | — | 0 | 0 | 7 | 112 | 125 | 144 | 190 | 240 | 278 | 483 | 1,283 |
| Gross margin | — | — | — | — | — | — | — | — | 75.4% | 82.3% | 75.7% | 76.6% | 77.5% | 78.5% | 76.4% | 79.7% | 84.4% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| ARIKAYCE | $434M | 71.5% | ▲ 19.3% |
| BRINSUPRI | $173M | 28.5% | — |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $453M | 74.7% | ▲ 77.8% |
| Outside the US | $153M | 25.3% | ▲ 40.9% |
From Insmed Inc's 10-K filed February 19, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Insmed Inc | $1.52bn | 240.0% | 75.6% |
| Halozyme Therapeutics, Inc. | $1.66bn | 41.2% | 29.1% |
| Alkermes plc. | $1.67bn | 10.8% | 4.5% |
| Madrigal Pharmaceuticals, Inc. | $1.28bn | 149.0% | — |
| Lakefront Biotherapeutics NV | $1.26bn | 321.6% | — |
| PTC Therapeutics, Inc. | $1.16bn | -35.1% | 13.1% |
Compare with peers
- Halozyme Therapeutics, Inc. revenue
- Alkermes plc. revenue
- Madrigal Pharmaceuticals, Inc. revenue
- Lakefront Biotherapeutics NV revenue
- PTC Therapeutics, Inc. revenue
Head to head: HALO vs INSMALKS vs INSMINSM vs MDGL
More: Biotechnology stocks compared, Health Care sector, rankings of US companies